Cello Health acquired for £182m by private equity firmCello Health has been acquired by Arsenal Capital Partners, a private equity firm investing in healthcare and industrials Share XCello Health acquired for £182m by private equity firmhttps://pharmaphorum.com/news/cello-health-arsenal-capital-partners/
Cello Health Insight brings Breaking Blue into the foldCello Health has merged its global tech and consumer research business Breaking Blue Research with its Cello Health Share XCello Health Insight brings Breaking Blue into the foldhttps://pharmaphorum.com/news/cello-health-insight-breaking-blue-research/
Cello Health acquires US consulting firm ISSCello Health has expanded its US footprint with the acquisition of New Jersey-based scientific consulting firm Innovative Science Share XCello Health acquires US consulting firm ISShttps://pharmaphorum.com/news/cello-health-us-consulting-firm-iss/
Cello Health Insight launches in GermanyCello Health has opened for business in Germany with the launch of a new Berlin office and appointment Share XCello Health Insight launches in Germanyhttps://pharmaphorum.com/news/cello-health-germany-heike-tombrink/
Defined Health becomes Cello Health BioConsultingCello’s US health consulting business Defined Health has been rebranded as Cello Health BioConsulting, following its acquisition by Share XDefined Health becomes Cello Health BioConsultinghttps://pharmaphorum.com/news/cello-health-bioconsulting-defined-health/
Cello Health acquires Firstlight PR’s health teamCello Health has boosted its comms offering with the acquisition of Firstlight Public Relations’ ten-strong healthcare business. The Share XCello Health acquires Firstlight PR’s health teamhttps://pharmaphorum.com/news/cello-health-acquires-firstlight-pr-health/
